Prasad Raju bought CRSP

January 6, 2026 · Form 4 insider transaction

Prasad Raju bought 23,361 shares of CRISPR Therapeutics AG at $45.15 per share, a transaction worth $1.05M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.